Zimmer Biomet Holdings Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 11:45PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. I'm Robbie Marcus, the medtech analyst at JPMorgan. Very happy to introduce our next session with Zimmer Biomet. I'm going to bring up Bryan Hanson, CEO, and then we'll do a little Q&A after. Bryan?

Bryan C. Hanson - Zimmer Biomet Holdings, Inc. - Chairman, President & CEO

Thanks, Robbie. All right. Hi. Can you guys hear me okay? All right, great. No applause, please. All right. So I'm obviously the Bryan Hanson, CEO of Zimmer Biomet, and I'm going to spend hopefully about 20 minutes going over some content that I think will be helpful for the discussion that we have after for the Q&A. This is the sexiest slide that I have in the deck. There's a lot of words on this. I'm not going to go through those words, thank goodness. But I think you guys know the story around forward-looking statements. So I'll give you a minute to peruse this just so legal knows you looked at it. That was the pause.

Okay. So here's -- I'm going to spend just a little

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot